Mrs. Alyson D Asparro, O.T.R./L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 233 Tyler Ave, Miller Place, NY 11764 Phone: 631-849-2231 |
Miss Elizabeth Lynne Haisman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 496 Miller Place Rd, Miller Place, NY 11764 Phone: 516-983-9891 |
Miss Jenna Catherine Ferrara, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 356 Tyler Ave, Miller Place, NY 11764 Phone: 631-252-3992 |
Marian Margaretta Marshall, O.T.R./L. Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15 Dogwood Hollow Ln, Miller Place, NY 11764 Phone: 631-928-8289 Fax: 631-331-8024 |
Mr. Richard Farrell, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 8 Henearly Dr, Miller Place, NY 11764 Phone: 631-275-4548 |
Mrs. Rizziene Sedayao, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19 Imperial Dr, Miller Place, NY 11764 Phone: 917-741-7269 |
Kathleen Sottilo Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4 Tree Rd, Miller Place, NY 11764 Phone: 631-445-5473 |
Ms. Courtney Gail Deatrich, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 250 Harrison Ave, Miller Place, NY 11764 Phone: 631-312-6753 Fax: 631-821-9844 |
News Archive
Massachusetts House leaders released a major proposal to curb health care costs Friday, calling for new limits on the fees charged by hospitals and doctors and for creation of an independent agency to monitor medical spending.
As California trudges into another autumn marred by toxic wildfire smoke and drought-parched reservoirs, state lawmakers have cast climate change as a growing public health threat for the state's 40 million residents.
Nurses trained to deliver eye injections for patients with the wet form of age-related macular degeneration (AMD) administered the treatments as safely and effectively as doctors, according to a new study. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Denver, Colo.
Ambit Biosciences Corporation and Astellas Pharma Inc. announced today results from a planned interim analysis in an ongoing Phase 2 study evaluating AC220, a potent and selective FLT3 inhibitor.
Two new studies presented today at the Society of NeuroInterventional Surgery 12th Annual Meeting in San Francisco, report that Mobile Stroke Treatment Units (MSTUs) can significantly reduce the time it takes to diagnose and treat patients for stroke, greatly improving survival rates and enhancing a patient's chance of recovery.
› Verified 8 days ago